Evidence map›Paper›PMID 36812562›Full record

ArticlePLOS digital health2022

Comparing different versions of computer-aided detection products when reading chest X-rays for tuberculosis.

Zhi Zhen Qin, Rachael Barrett, Shahriar Ahmed, Mohammad Shahnewaz Sarker, Kishor Paul, Ahammad Shafiq Sikder Adel, Sayera Banu, Jacob Creswell

Abstract read
In one paragraph

Article in PLOS digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhi Zhen QinStop TB Partnership, Le Grand-Saconnex, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-3956-5223
Rachael BarrettStop TB Partnership, Le Grand-Saconnex, Geneva, Switzerland.ORCID https://orcid.org/0000-0001-5004-2573
Shahriar AhmedInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.ORCID https://orcid.org/0000-0002-8833-4130
Mohammad Shahnewaz SarkerInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Kishor PaulInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.ORCID https://orcid.org/0000-0002-6054-3571
Ahammad Shafiq Sikder AdelInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.ORCID https://orcid.org/0000-0002-3765-5153
Sayera BanuInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Jacob CreswellStop TB Partnership, Le Grand-Saconnex, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer-aided detection (CAD) was recently recommended by the WHO for TB screening and triage based on several evaluations, but unlike traditional diagnostic tests, software versions are updated frequently and require constant evaluation. Since then, newer versions of two of the evaluated products have already been released. We used a case control sample of 12,890 chest X-rays to compare performance and model the programmatic effect of upgrading to newer versions of CAD4TB and qXR. We compared the area under the receiver operating characteristic curve (AUC), overall, and with data stratified by age, TB history, gender, and patient source. All versions were compared against radiologist readings and WHO's Target Product Profile (TPP) for a TB triage test. Both newer versions significantly outperformed their predecessors in terms of AUC: CAD4TB version 6 (0.823 [0.816-0.830]), version 7 (0.903 [0.897-0.908]) and qXR version 2 (0.872 [0.866-0.878]), version 3 (0.906 [0.901-0.911]). Newer versions met WHO TPP values, older versions did not. All products equalled or surpassed the human radiologist performance with improvements in triage ability in newer versions. Humans and CAD performed worse in older age groups and among those with TB history. New versions of CAD outperform their predecessors. Prior to implementation CAD should be evaluated using local data because underlying neural networks can differ significantly. An independent rapid evaluation centre is necessitated to provide implementers with performance data on new versions of CAD products as they are developed.

Identifiers

PMID36812562
PMCPMC9931298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.